• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Micel Corporation

Micel Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. A Practical Guide to Managing Common Problems in Apparel Sourcing When Things Go Wrong - Research and Markets

    A Practical Guide to Managing Common Problems in Apparel Sourcing When Things Go Wrong - Research and Markets

  2. UPDATE: Lyme disease is threatening an unprecedented 2017

    UPDATE: Lyme disease is threatening an unprecedented 2017

  3. ASUS Republic of Gamers Brings NRG eSports Closer to Gaming Domination

    ASUS Republic of Gamers Brings NRG eSports Closer to Gaming Domination

  4. Inventiva Announces Presentation of Preclinical Results on IVA337 in NASH at the International Liver Congress™ 2017 (EASL)

    Inventiva Announces Presentation of Preclinical Results on IVA337 in NASH at the International Liver Congress™ 2017 (EASL)

  5. Enanta Announces New Preclinical Data on its FXR Agonist EDP-305 for Non-Alcoholic Steatohepatitis (NASH) and Primary Biliary Cholangitis (PBC) at The International Liver Congress™ 2017

    Enanta Announces New Preclinical Data on its FXR Agonist EDP-305 for Non-Alcoholic Steatohepatitis (NASH) and Primary Biliary Cholangitis (PBC) at The International Liver Congress™ 2017

  6. Promethera Biosciences Presents Preclinical Data on Novel H2Stem Cell Therapy at EASL International Liver Congress

    Promethera Biosciences Presents Preclinical Data on Novel H2Stem Cell Therapy at EASL International Liver Congress

  7. Logitech G Launches G413 Mechanical Gaming Keyboard With Exclusive Romer-G Mechanical Switches

    Logitech G Launches G413 Mechanical Gaming Keyboard With Exclusive Romer-G Mechanical Switches

  8. Egaceutical Corporation Demonstrates Human Age Reversal, Patent is Pending

    Egaceutical Corporation Demonstrates Human Age Reversal, Patent is Pending

  9. Chi-Med Presented Pre-clinical Data for Fruquintinib and Sulfatinib at the American Association for Cancer Research Annual Meeting 2017

    Chi-Med Presented Pre-clinical Data for Fruquintinib and Sulfatinib at the American Association for Cancer Research Annual Meeting 2017

  10. ABIVAX Expands Its Antiviral Portfolio with Compounds Targeting Zika Virus

    ABIVAX Expands Its Antiviral Portfolio with Compounds Targeting Zika Virus

123

©2017 Morningstar Advisor. All right reserved.